These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 23688319)

  • 1. Maternal plasma soluble TRAIL is decreased in preeclampsia.
    Chaemsaithong P; Chaiworapongsa T; Romero R; Korzeniewski SJ; Stampalija T; Than NG; Dong Z; Miranda J; Yeo L; Hassan SS
    J Matern Fetal Neonatal Med; 2014 Feb; 27(3):217-27. PubMed ID: 23688319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble TRAIL in normal pregnancy and acute pyelonephritis: a potential explanation for the susceptibility of pregnant women to microbial products and infection.
    Chaemsaithong P; Romero R; Korzeniewski SJ; Schwartz AG; Stampalija T; Dong Z; Yeo L; Hernandez-Andrade E; Hassan SS; Chaiworapongsa T
    J Matern Fetal Neonatal Med; 2013 Nov; 26(16):1568-75. PubMed ID: 23480056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower maternal serum tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) levels in early preeclampsia. A retrospective study.
    Morano D; Rolfo A; Tisato V; Farina A; Rimondi E; Scutiero G; Greco P; Bonaccorsi G; Todros T
    Pregnancy Hypertens; 2018 Apr; 12():1-5. PubMed ID: 29674187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes.
    Adekola H; Romero R; Chaemsaithong P; Korzeniewski SJ; Dong Z; Yeo L; Hassan SS; Chaiworapongsa T
    J Matern Fetal Neonatal Med; 2015; 28(14):1621-32. PubMed ID: 25211383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The circulating soluble TRAIL is a negative marker for inflammation inversely associated with the mortality risk in chronic kidney disease patients.
    Liabeuf S; Barreto DV; Barreto FC; Chasseraud M; Brazier M; Choukroun G; Kamel S; Massy ZA
    Nephrol Dial Transplant; 2010 Aug; 25(8):2596-602. PubMed ID: 20190248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anti-aging factor α-klotho during human pregnancy and its expression in pregnancies complicated by small-for-gestational-age neonates and/or preeclampsia.
    Miranda J; Romero R; Korzeniewski SJ; Schwartz AG; Chaemsaithong P; Stampalija T; Yeo L; Dong Z; Hassan SS; Chrousos GP; Gold P; Chaiworapongsa T
    J Matern Fetal Neonatal Med; 2014 Mar; 27(5):449-57. PubMed ID: 23808483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased placental expression and maternal serum levels of apoptosis-inducing TRAIL in recurrent miscarriage.
    Rull K; Tomberg K; Kõks S; Männik J; Möls M; Sirotkina M; Värv S; Laan M
    Placenta; 2013 Feb; 34(2):141-8. PubMed ID: 23290504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate.
    Romero R; Nien JK; Espinoza J; Todem D; Fu W; Chung H; Kusanovic JP; Gotsch F; Erez O; Mazaki-Tovi S; Gomez R; Edwin S; Chaiworapongsa T; Levine RJ; Karumanchi SA
    J Matern Fetal Neonatal Med; 2008 Jan; 21(1):9-23. PubMed ID: 18175241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of post-cardioversion transcardiac concentration gradient of soluble tumor necrosis factor-related apoptosis-inducing ligand (sTRAIL) and inflammatory biomarkers to atrial fibrillation recurrence.
    Deftereos S; Giannopoulos G; Kossyvakis C; Raisakis K; Angelidis C; Efremidis M; Panagopoulou V; Kaoukis A; Theodorakis A; Toli K; Zavitsanakis P; Mantas I; Pyrgakis V; Stefanadis C; Cleman MW
    Clin Biochem; 2013 Aug; 46(12):1020-1025. PubMed ID: 23481489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory disturbances in preeclampsia: relationship between maternal and umbilical cord blood.
    Catarino C; Santos-Silva A; Belo L; Rocha-Pereira P; Rocha S; Patrício B; Quintanilha A; Rebelo I
    J Pregnancy; 2012; 2012():684384. PubMed ID: 22685662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placental growth hormone is increased in the maternal and fetal serum of patients with preeclampsia.
    Mittal P; Espinoza J; Hassan S; Kusanovic JP; Edwin SS; Nien JK; Gotsch F; Than NG; Erez O; Mazaki-Tovi S; Romero R
    J Matern Fetal Neonatal Med; 2007 Sep; 20(9):651-9. PubMed ID: 17701665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble tumor necrosis factor related apoptosis inducing ligand level as a predictor of severity of sepsis and the risk of mortality in septic patients.
    Tian Y; Tao T; Zhu J; Zou Y; Wang J; Li J; Bo L; Deng X
    PLoS One; 2013; 8(12):e82204. PubMed ID: 24349222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma levels of inflammatory markers neopterin, sialic acid, and C-reactive protein in pregnancy and preeclampsia.
    von Versen-Hoeynck FM; Hubel CA; Gallaher MJ; Gammill HS; Powers RW
    Am J Hypertens; 2009 Jun; 22(6):687-92. PubMed ID: 19282816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tumor necrosis factor-related apoptosis-inducing ligand gene polymorphism and its plasma phenotype in relation to Crohn's disease].
    Zhu HQ; Hu P; Xu F; Shao XX; Cao SG; Wu H; Jiang Y
    Zhonghua Yi Xue Za Zhi; 2023 Feb; 103(8):585-593. PubMed ID: 36822870
    [No Abstract]   [Full Text] [Related]  

  • 15. Maternal plasma fetuin-A concentration is lower in patients who subsequently developed preterm preeclampsia than in uncomplicated pregnancy: a longitudinal study.
    Chaemsaithong P; Romero R; Tarca AL; Korzeniewski SJ; Schwartz AG; Miranda J; Ahmed AI; Dong Z; Hassan SS; Yeo L; Tinnakorn T
    J Matern Fetal Neonatal Med; 2015; 28(11):1260-1269. PubMed ID: 25115163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Association between plasma levels of soluble leukocyte differentiation antigens CD₄₀/CD₄₀ ligand and kidney damage in preeclamptic patients].
    Qin W; Zhan Y; Ye YH; Li C; Cui XN
    Zhonghua Fu Chan Ke Za Zhi; 2011 Aug; 46(8):582-6. PubMed ID: 22169515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Annexin A1 Is Increased in the Plasma of Preeclamptic Women.
    Perucci LO; Carneiro FS; Ferreira CN; Sugimoto MA; Soriani FM; Martins GG; Lima KM; Guimarães FL; Teixeira AL; Dusse LM; Gomes KB; Sousa LP
    PLoS One; 2015; 10(9):e0138475. PubMed ID: 26398190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal plasma-soluble ST2 concentrations are elevated prior to the development of early and late onset preeclampsia - a longitudinal study.
    Romero R; Chaemsaithong P; Tarca AL; Korzeniewski SJ; Maymon E; Pacora P; Panaitescu B; Chaiyasit N; Dong Z; Erez O; Hassan SS; Chaiworapongsa T
    J Matern Fetal Neonatal Med; 2018 Feb; 31(4):418-432. PubMed ID: 28114842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal plasma concentrations of sST2 and angiogenic/anti-angiogenic factors in preeclampsia.
    Stampalija T; Chaiworapongsa T; Romero R; Chaemsaithong P; Korzeniewski SJ; Schwartz AG; Ferrazzi EM; Dong Z; Hassan SS
    J Matern Fetal Neonatal Med; 2013 Sep; 26(14):1359-70. PubMed ID: 23488689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal and umbilical cord procalcitonin, high-sensitivity C-reactive protein, and interleukin-6 levels in preeclamptic and normotensive patients: A cross-sectional study.
    Lumbreras-Marquez MI; Lumbreras-Marquez J; Barraza-Salas M; Castillo-Reyther RA; De la Maza-Labastida S; Hernandez-Rayon YI; Farber MK; Vazquez-Alaniz F
    Pregnancy Hypertens; 2020 Jul; 21():218-223. PubMed ID: 32683282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.